AngloGold Ashanti

silicosis

Silicosis class action settlement becomes effective

The silicosis settlement agreement reached on 3 May 2018, which is an outcome of the silicosis and tuberculosis class action litigation, has become effective.
Shanta Gold

ICYMI: AngloGold Ashanti’s historic Obuasi mine pours first gold

AngloGold Ashanti’s wholly-owned subsidiary, AngloGold Ashanti (Ghana), has poured first gold from the Obuasi gold mine in Ghana.
gold solar lithium

ICYMI: IAMGOLD to sell interests in Sadiola gold mine

IAMGOLD and its JV partner will sell its collective interests in Société d'Exploitation des Mines d'Or de Sadiola S.A. to Allied Gold Corp.
gold

Gold exploration vital for future supply

Concern about the global economy has spurred the increase in gold price as central banks adopt a more dovish tone and the FED cutting interest rates.
Silicosis

Court approves settlement of the silicosis and TB class action

A full bench of the Johannesburg High Court has approved the settlement of the silicosis and tuberculosis class action suit.
ghana

Cardinal Resources eyes improving cost structures in Ghana

Cardinal Resources is expected to finalise the Feasibility Study for its Namdini project in Ghana in the September quarter.
ghana

GoldStone Resources: Reawakening a gold giant in Ghana

As Africa’s second largest gold producer Ghana is well on its way to reclaiming the top spot as Africa’s largest gold producer.
AngloGold Ashanti

Solidarity urges AngloGold Ashanti to act responsibly during Mponeng sale

Solidarity is not surprised that AngloGold Ashanti’s is possibly going to sell Mponeng, but has urged the company to act responsibly.
AngloGold Ashanti

AngloGold Ashanti’s SA exit strategy kicks into final gear

AngloGold Ashanti has confirmed it is embarking on a process to review divestment options for its remaining South African assets.
Kibali

Kibali makes strong statement for 2019 production

Kibali has made a strong start to 2019 after setting a new production record last year says Barrick President and CEO, Mark Bristow.

Latest Feature